Castleark Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-52,908
Closed -$3.14M 343
2021
Q3
$3.14M Sell
52,908
-2,720
-5% -$161K 0.12% 160
2021
Q2
$4.83M Sell
55,628
-2,850
-5% -$247K 0.16% 142
2021
Q1
$4.82M Buy
58,478
+14,128
+32% +$1.16M 0.17% 138
2020
Q4
$4.03M Buy
+44,350
New +$4.03M 0.15% 147